Clinical Topics & News

Clinical Puzzle: Lung Cancer or Hodgkin Lymphoma?

Making the right diagnosis when the radiologic evidence is misleading.


 

Patients with Hodgkin lymphoma have a 15% to 40% likelihood of pulmonary involvement, such as a solitary lung mass or cavitary lung lesion. But clinicians at Bassett Healthcare in Cooperstown, New York, were faced with a rare case of another presentation: an endobronchial obstructing mass.

The patient, a 40-year-old man, reported having had cough, fatigue, and progressive weight loss (despite a good appetite) for 8 months. Because he had a history of smoking, he was treated for bronchitis, but the cough worsened. He had no fever, night sweats, dyspnea, or chest pain (common features of Hodgkin lymphoma).

Auscultation revealed clear lungs, with no crackles or wheeze, and no dullness to percussion. Blood work was negative except for eosinophilia. A subsequent chest radiograph showed an irregular left hilar lung opacity. A computer tomography scan showed a cavitary consolidation of the left upper lobe of the lung. Fiber-optic bronchoscopy with tissue from the endobronchial mass indicated an obstructing lesion in the left upper lobe bronchus. The clinicians suspected lung cancer.

Timeliness of Lung Cancer Diagnosis and Treatment (FULL)

However, they also found inflammatory cells, and immunohistochemistry revealed findings consistent with Hodgkin lymphoma. The clinicians started the patient on chemotherapy. After 6 cycles, his symptoms resolved. Follow-up at 8 months showed no clinical evidence of recurrence.

As the clinicians found out, radiologically, Hodgkin lymphoma can mimic lung cancer. They advise histopathologic diagnosis for a patient presenting with lung mass.

Source:
Abid H, Khan J, Lone N. BMJ Case Rep. 2018;2018. pii: bcr-2017-223809.
doi: 10.1136/bcr-2017-223809.

Recommended Reading

The Challenges of Precision Medicine and New Advances in Molecular Diagnostic Testing in Hematolymphoid Malignancies: Impact on the VHA (FULL)
AVAHO
Improving Access and Workflow in Radiation Oncology in an Attempt to Decrease Time Between Cancer Diagnosis and First Treatment
AVAHO
When Genetic Testing Is Not the Best Care Anywhere
AVAHO
Abstracts Presented at the 2017 AVAHO Annual Meeting (Digital Edition)
AVAHO
FDA Approves Treatment for Chronic GVHD
AVAHO
Treatment and Management of Multiple Myeloma (FULL)
AVAHO
VA Central California Improves Access to Clinical Trials
AVAHO
Can Albumin/Globulin Levels Predict Digestive Cancer Prognosis?
AVAHO
Treating Cancer Fatigue With Placebo
AVAHO
Call for Articles on Hematology/Oncology
AVAHO